US companies who want a piece of Europe’s AI market are starting to make concessions to concerns over technological and data ...

As AI accelerates across biopharma and other science-driven industries, organizations are encountering a critical bottleneck: ...

The authors propose a novel framework that embeds AI drug discovery workflows within the familiar Electronic Lab Notebook (ELN) interface, making advanced AI tools accessible to bench chemists without ...

Gregory McVay, group vice president and chief customer officer at Danaher Life Sciences, discusses how automation and AI can ...

Foundation model-powered dual-module system establishes a new performance benchmark for AI-driven peptide drug ...

NIIMBL’s 2025 National Meeting emphasized the need for system interoperability through standardization of means for data ...

In the new open-access volume Archives of Science: Challenges and Opportunities in the 21st Century, editors Polina Ilieva ...

Both small and large companies trust LabVantage—the most flexible and commercially available informatics solution—across various industries to operate their laboratories. LabVantage’s platform helps ...

Drug Discovery Software Market OverviewThe global drug discovery software market is emerging as a high-impact segment within the life sciences technology ecosystem, driven by the urgent need for ...

SEDEMAC demonstrated what is possible when exceptional founders build with conviction through conditions that required them ...

Near the height of the COVID-19 pandemic, Boston University made the bold decision to resume in-person learning for its autumn 2020 semester. Part of that choice stemmed from the fact that the campus ...